肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2009年
3期
183-184,187
,共3页
裴毅%魏淑青%杨永明%任晓辉%黄金
裴毅%魏淑青%楊永明%任曉輝%黃金
배의%위숙청%양영명%임효휘%황금
肿瘤%促甲状腺素%三碘甲状腺原氨酸%甲状腺素%蛋白质组
腫瘤%促甲狀腺素%三碘甲狀腺原氨痠%甲狀腺素%蛋白質組
종류%촉갑상선소%삼전갑상선원안산%갑상선소%단백질조
Neoplasms%Thyrotropin%Triiodothyronine%Thyroxine%Proteome
目的 探索癌症患者病情危重至死亡发生前促甲状腺素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)的变化情况.方法 能接受抗肿瘤治疗且不伴有甲状腺疾病的晚期癌症患者84例,年龄24~85岁,男56例,女28例,行表面增强激光解析/电离飞行时间质谱蛋白芯片技术(SELDI技术)检查,以质荷比(M/Z)为11 100+H~11 900+H有无峰簇,分成危重患者预警蛋白(LGT)阳性组和阴性组.所有患者行TSH、FT3、FT4检查,对结果行统计学分析.结果 LGT阳性组TSH、FT3、FT4值显著低于LGT阴性组.在LGT阳性组中,TSH、FT3、FT4之间无相关性;LGT阴性组中,FT3与FT4之间呈正相关,而与TSH无相关性.结论 肿瘤患者病情稳定阶段机体的甲状腺功能基本是正常的,当处于疾病末期及死亡发生前期,有可能出现垂体-甲状腺功能低下,这有可能是加速患者死亡的一个重要因素,但这个现象的出现与LGT高表达之间的因果关系尚不明确.在患者病情危重时检查甲状腺功能,并根据结果补充适量的甲状腺激素是有益的.
目的 探索癌癥患者病情危重至死亡髮生前促甲狀腺素(TSH)、遊離三碘甲狀腺原氨痠(FT3)、遊離甲狀腺素(FT4)的變化情況.方法 能接受抗腫瘤治療且不伴有甲狀腺疾病的晚期癌癥患者84例,年齡24~85歲,男56例,女28例,行錶麵增彊激光解析/電離飛行時間質譜蛋白芯片技術(SELDI技術)檢查,以質荷比(M/Z)為11 100+H~11 900+H有無峰簇,分成危重患者預警蛋白(LGT)暘性組和陰性組.所有患者行TSH、FT3、FT4檢查,對結果行統計學分析.結果 LGT暘性組TSH、FT3、FT4值顯著低于LGT陰性組.在LGT暘性組中,TSH、FT3、FT4之間無相關性;LGT陰性組中,FT3與FT4之間呈正相關,而與TSH無相關性.結論 腫瘤患者病情穩定階段機體的甲狀腺功能基本是正常的,噹處于疾病末期及死亡髮生前期,有可能齣現垂體-甲狀腺功能低下,這有可能是加速患者死亡的一箇重要因素,但這箇現象的齣現與LGT高錶達之間的因果關繫尚不明確.在患者病情危重時檢查甲狀腺功能,併根據結果補充適量的甲狀腺激素是有益的.
목적 탐색암증환자병정위중지사망발생전촉갑상선소(TSH)、유리삼전갑상선원안산(FT3)、유리갑상선소(FT4)적변화정황.방법 능접수항종류치료차불반유갑상선질병적만기암증환자84례,년령24~85세,남56례,녀28례,행표면증강격광해석/전리비행시간질보단백심편기술(SELDI기술)검사,이질하비(M/Z)위11 100+H~11 900+H유무봉족,분성위중환자예경단백(LGT)양성조화음성조.소유환자행TSH、FT3、FT4검사,대결과행통계학분석.결과 LGT양성조TSH、FT3、FT4치현저저우LGT음성조.재LGT양성조중,TSH、FT3、FT4지간무상관성;LGT음성조중,FT3여FT4지간정정상관,이여TSH무상관성.결론 종류환자병정은정계단궤체적갑상선공능기본시정상적,당처우질병말기급사망발생전기,유가능출현수체-갑상선공능저하,저유가능시가속환자사망적일개중요인소,단저개현상적출현여LGT고표체지간적인과관계상불명학.재환자병정위중시검사갑상선공능,병근거결과보충괄량적갑상선격소시유익적.
Objective Exploration of TSH, FT3, FT4 changes in critical condition prior to death.Methods 84 patients that were anti-tumor therapy acceptable and not associated with the treatment of thyroid disease in patients with terminal tumors. Age from 24 to 85-year-old, male 56, female 28. The use of SELDI technology (surface-enhanced laser description / ionization time-of-flight mass spectrometry protein chip technology) checks to M/Z for the 11 100 + H~11 900 + H peak of the cluster, divided into the positive group for critically ill patients with early warning protein (LGT) and the negative group for it. All patients were given TSH, FT3, FT4 inspection. The results were statistically analyzed. Results TSH, FT3, FT4 in the LGT positive group was significantly lower than in the negative LGT group. There was no correlation between TSH,FT3 and FT4 in the LGT positive group;In the negative LGT group FT3 and FT4 had a positive correlation,and FT3 and TSH no relevance. Conclusion Thyroid function is normal in the stage of cancer patients stable condition. Possible pituitary-hypothyroidism may occur as the disease advances to the end or before death.This may be an important factor causing the acceleration to the death of the patients. However, the cause and effect between this phenomenon and the early warning of protein fingerprint group(LGT) is still not clear. In critical condition checking thyroid function and render supplementary amount of thyroid hormone in accordance with the checking results may be beneficial.